Cytocybernetics' Biz Plan Competition Round

Cytocybernetics raised a round of funding on October 29, 2015. Investors include 43North.

Cytocybernetics has developed novel technology to improve drug safety screening. Its product, the Cybercyte, will ensure that new drugs brought to market do not cause cardiac arrhythmias as a side eff…

Articles about Cytocybernetics' Biz Plan Competition Round: